Riskpilot← Back to searchSign inGet full accessColosseum Taastrup ApS
APSActiveCVR 32338747Herlev Bygade 14, 1.Dental practice care activities · NACE 8623Est. 20131 employeeshttps://colosseumtand.dk/taastrup/
Revenue 2024
DKK -79K
-104% vs 2023
EBITDA margin
-587.7%
+135% vs 2023
Equity ratio
-4133.2%
Financial strength
Net profit 2024
DKK 570K
+137% vs 2023
| Revenue | DKK -79K | -104% |
| EBITDA | DKK 461K | +135% |
| Net profit | DKK 570K | +137% |
| Total assets | DKK 111K | -86% |
| Equity | DKK -4,6M | +11% |
| Employees | 1 | — |
Legal name
Colosseum Taastrup ApS
CVR number
32338747
Legal form
Anpartsselskab
NACE code
8623 · Dental practice care activities
Founded
25. juni 2013
Share capital
DKK 80.000
Employees
1 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør i forening med bestyrelsesformanden
Company purpose
Selskabets formål er at drive tandlægevirksomhed samt anden virksomhed, der er naturligt forbundet hermed.
Address
Herlev Bygade 14, 1.
Phone
+4588802680
Email
Taastrup@colosseumklinikken.dk
Website
https://colosseumtand.dk/taastrup/
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -37 | 2.657 | 2.924 | 3.385 | 4.472 | 3.617 | 5.159 | 3.760 | 4.729 | 2.983 | 1.994 | -79 |
| Staff expenses | -0 | -2.890 | -3.979 | -3.596 | -3.783 | -4.032 | -5.197 | -4.488 | -5.272 | -3.442 | -3.308 | -35 |
| EBITDA | -37 | -233 | -1.055 | -211 | 688 | -415 | -38 | -728 | -543 | -458 | -1.313 | 461 |
| Depreciation & amort. | -12 | -183 | -197 | -193 | -427 | -536 | -134 | -124 | -236 | -244 | -217 | 253 |
| EBIT | -50 | -417 | -1.253 | -404 | 262 | -951 | -173 | -851 | -780 | -702 | -1.531 | 209 |
| Net financials | -0 | -44 | 0 | -28 | -29 | -3 | -24 | -27 | -79 | -24 | -12 | -25 |
| Profit before tax | -50 | -461 | -1.252 | -432 | 233 | -954 | -197 | -879 | -859 | -725 | -1.543 | 184 |
| Tax | -13 | -101 | -172 | -199 | 80 | -210 | 50 | 603 | -0 | -0 | -0 | -386 |
| Net profit | -36 | -360 | -1.081 | -234 | 153 | -744 | -247 | -1.482 | -859 | -725 | -1.543 | 570 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.020 | 1.641 | 1.723 | 1.613 | 2.417 | 4.123 | 2.217 | 1.657 | 1.077 | 1.210 | 806 | 111 |
| Equity | 44 | -316 | -1.396 | 309 | 462 | -282 | -529 | -2.011 | -2.870 | -3.595 | -5.138 | -4.568 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 73 | 119 | 119 | 119 | 119 | 134 |
| Short-term debt | 976 | 1.957 | 3.120 | 1.304 | 1.955 | 4.405 | 2.672 | 3.549 | 3.828 | 4.687 | 5.825 | 4.545 |
| Total debt | 976 | 1.957 | 3.120 | 1.304 | 1.955 | 4.405 | 2.745 | 3.668 | 3.946 | 4.805 | 5.944 | 4.679 |
EBITDA margin
46145900.0%
This company
15.8%
Market median
+292062558% vs market
20132024
Equity ratio
-4133.2%
This company
38.2%
Market median
-10920% vs market
20132024
Return on equity
56963700.0%
This company
18.4%
Market median
+309585226% vs market
20132024
Net profit margin
56963700.0%
This company
8.1%
Market median
+703255456% vs market
20132024
Asset turnover
-0.71×
This company
1.12×
Market median
-163% vs market
20132024
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-06-25 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
MB Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
DS Management | Management | 2013 | — | — |
NK Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2013 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Chairman | 2016 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2016 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Tandlæge Erik Andersen Holding ApS | Company | 50.0% | 50.0% | 2022 |
Dentin Holding ApS | Company | 33.3% | 33.3% | 2016 |
Tandlægerne i Gentofte ApS | Company | 50.0% | 50.0% | 2015 |
| Individual | 50.0% | 50.0% | 2022 | |
| Individual | 50.0% | 50.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tandlæge Erik Andersen Holding ApS
Colosseum Taastrup ApS Board members of Colosseum Taastrup ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Schat-Holm | Chief Executive Officer | 0 companies |
| Malin Birgitta Schmidt | Chief Executive Officer | 0 companies |
| Dimitrios Spiliopoulos | Management | 0 companies |
| Nils Kjell Niklas Odengard | Chief Executive Officer | 0 companies |
| Martin Ratz | Chairman | 0 companies |
| Rasmus Maahr | Board of Directors | 0 companies |
| Peter Martedal | Board of Directors | 0 companies |
| Mathias Riis Damgaard | Board of Directors | 0 companies |
| Christian Rydiander Toelhøj | Board of Directors | 0 companies |
| Søren Kock | Chairman | 0 companies |
| Dominique Nicole Dr. Friederich | Board of Directors | 0 companies |
| Jerry Mathen George | Chairman | 0 companies |
| Frans Maarten van Berckel | Board of Directors | 0 companies |
| Jacob Adelbertus Cornelis Vermeule | Board of Directors | 0 companies |
| Jens Mondrup | Chairman | 0 companies |
| Christopher Sebastian Östberg | Board of Directors | 0 companies |